Lexicon Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$1.32(as of Dec 9, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Lexicon Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$1.32
Ticker SymbolLXRX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees103
CountyUSA
Market Cap$494.2M
EBIDTA-53.9M
10-Day Moving Average1.40
P/E Ratio-7.10
20-Day Moving Average1.41
Forward P/E Ratio0.00
50-Day Moving Average1.42
Earnings per Share-0.19
200-Day Moving Average0.95
Profit Margin-90.04%
RSI45.22
Shares Outstanding363.4M
ATR0.10
52-Week High1.66
Volume772,272
52-Week Low0.28
Most Recent Support Level1.28
Book Value120.2M
Most Recent Resistance Level1.47
P/B Ratio4.05
Upper Keltner1.63
P/S Ratio6.87
Lower Keltner1.20
Debt-to-Equity Ratio1.63
Next Earnings DateUnknown
Cash Surplus27.9M
Next Ex-Dividend DateUnknown

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company offers Sotagliflozin, an orally-delivered small molecule drug to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease or CKD, and other cardiovascular risk factors. Its orally-delivered small molecule drug candidates under development include sotagliflozin for the treatment of hypertrophic cardiomyopathy or HCM and type 1 diabetes that is in Phase 3 clinical trial; LX9211, which has completed Phase II clinical trials for the treatment of neuropathic pain; and LX9851 for the treatment of obesity and associated cardiometabolic disorders, as well as for weight management. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Lexicon Pharmaceuticals Inc In Our Stock Scanner

As of Dec 09, 2025
example chart graphic
Scan Name: WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.